semaglutide ban update What to know about the compounded FDA Ban on Compounded GLP-1

CJC-1295 clinical dosing in trials used microgram/kg regimens (e.g., doses like 3060 g/kg in early research)

PlexusDx offers oral semaglutide ($289/mo month-to-month, or from $249/mo on the 6-month plan) and oral tirzepatide ($349/mo month-to-month, or from $279/mo on the 6-month plan) as alternatives for those with significant injection-site complications or needle anxiety, all compounded to licensed 503A standards

Jeffries suggests outcomes-based agreements as a possibility: Tying reimbursement to outcomes could mitigate risk for both manufacturers and payers it will be interesting to see if that model gains traction. References: Nguyen T, Wong E, Cope R

Get a personalized quote for your specific ZIP code